NYSE · CIK 0000310764 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
STRYKER CORP
SYK chart by TradingView
PRICE HISTORY
LIVE · NYSESYK chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $25.1B
- EBITDA
- $6.5B
- FREE CASH FLOW
- $4.3B
- EPS
- $8.40
- GROSS MARGIN
- 63.96%
- ROIC
- 9.47%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
32.6x
+23%16.8x66.0x
⤢
P / SALES (TTM)
4.7x
+16%4.0x6.6x
⤢
P / BOOK
5.1x
+7%4.7x7.2x
⤢
EV / EBITDA (TTM)
18.6x
+9%16.7x32.9x
⤢
EV / REVENUE (TTM)
5.2x
+17%4.3x7.3x
⤢
FCF YIELD (TTM)
3.87%
+0.3pp1.63%3.87%
⤢
DIVIDEND YIELD (TTM)
—
-1.3pp0.66%1.96%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$6.6B
+133%⤢
EBITDA (DERIVED)
$2.1B
+258%⤢
NET INCOME
$1.3B
+259%⤢
EPS (DILUTED)
$3.31
+253%⤢
REVENUE GROWTH YOY
9.42%
-7.7pp-24.27%55.35%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
16.07%
+2.5pp-2.10%26.15%
⤢
RETURN ON CAPITAL
10.49%
-2.0pp5.79%19.77%
⤢
RETURN ON EQUITY (TTM)
15.55%
-2.2pp10.23%30.29%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN68.27%
OPERATING MARGIN25.18%
NET MARGIN19.37%
FCF MARGIN16.07%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$1.1B
+176%⤢
STOCK-BASED COMP
$0.1B
+145%⤢
CAPITAL EXPENDITURE
$0.2B
+71%⤢
SHARES OUTSTANDING
0.39B
+2%⤢
DIVIDEND / SHARE
$0.88
-23%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$3.4B
+15%⤢
TOTAL DEBT
$14.9B
+118%⤢
DEBT / EBITDA (TTM)
2.1x
-14%2.1x4.2x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 82.25%INSIDERS 5.36%OTHER / RETAIL 12.39%3,048 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 7.20% | 27.6M | $9.36B | +0.6% |
| Vanguard Capital Management LLC | 5.84% | 22.4M | $7.59B | NEW |
| JPMORGAN CHASE & CO | 4.07% | 15.6M | $5.29B | +28.4% |
| State Street Corporation | 4.00% | 15.3M | $5.20B | +0.6% |
| Greenleaf Trust | 3.97% | 15.2M | $5.16B | -4.4% |
| Price (T.Rowe) Associates Inc | 2.62% | 10.0M | $3.40B | -0.8% |
| Vanguard Portfolio Management LLC | 2.17% | 8.3M | $2.83B | NEW |
| Wellington Management Group, LLP | 2.12% | 8.1M | $2.75B | +25.1% |
| Geode Capital Management, LLC | 2.02% | 7.7M | $2.63B | +2.8% |
| Morgan Stanley | 1.64% | 6.3M | $2.14B | +0.8% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.